That frequency was higher for both inhalers and patients who ingested cannabis at the end of the study period than the start, with the rate for ingesting patients steadily increasing over the 24 months studied.
“We’ve got to keep educating patients on the risks of cannabis use” even in the ED, Leach stressed.
Study limitations included the restrospective design, which limited causality; the potential for reporting bias; and localization to western Michigan.
The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider.